| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |